Synthetic Strategies and Biological Activities of Pyrazolo[4,3-e]pyrrolo[1,2- a]pyrazines and Related Tricyclic Systems: A Comprehensive Literature Review.

Abstract

Nitrogen-containing heterocyclic compounds with multiple fused rings have gained significant interest in medicinal chemistry due to their structural versatility and wide range of pharmacological applications. Within this category, pyrazolopyrrolopyrazines stand out as scaffolds featuring a tricyclic fused core composed of pyrazole, pyrrole, and pyrazine rings. These molecules have demonstrated promising biological activities, including potent antibacterial and antifungal properties, significant inhibition of phosphodiesterase type 5 (PDE5), and other activities. Moreover, analogous molecules have shown potential applications as antioxidants, anti-inflammatory agents, antitumor compounds, regulators of the vasopressin receptor AVPR1b, among others. Despite their potential, the development of unified and efficient synthetic methodologies for specific isomers- particularly less explored structural variants-remains limited and fragmented across the literature. This mini-review provides a comprehensive analysis of the synthetic strategies and biological potential of pyrazolo[4,3-e]pyrrolo[1,2-a]pyrazine isomers and related tricyclic systems. This study discusses selected synthetic methodologies reported in the literature, ranging from classical synthetic methods to modern catalytic approaches, aiming to facilitate access to these heterocyclic analogs. Furthermore, this work identifies an existing research gap through the lack of systematic studies on the pyrazolo[3,4-e] isomer. To address this limitation, this study proposes a novel retrosynthetic strategy based on the stepwise construction of the tricyclic core from readily available 5- aminopyrazoles. This approach integrates well-established transformations, including nitrosations, reductions, Clauson-Kaas pyrrole formation, and Pictet-Spengler-type cyclization, for strategically construct this isomer of interest. This study presents precise and detailed breakdowns of each step, with the expressed priority of identifying common ground in analogous structures and reactivity between the literature and the proposal. By consolidating current knowledge, this review seeks to open new avenues for research on the design and functionalization of pyrazolopyrrolopyrazine derivatives, providing medicinal chemists with a valuable toolkit for developing new bioactive entities.